BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17287256)

  • 1. Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells.
    Di Piazza M; Mader C; Geletneky K; Herrero Y Calle M; Weber E; Schlehofer J; Deleu L; Rommelaere J
    J Virol; 2007 Apr; 81(8):4186-98. PubMed ID: 17287256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic implications of the enhanced short and long-term cytotoxicity of radiation treatment followed by oncolytic parvovirus H-1 infection in high-grade glioma cells.
    Geletneky K; Hartkopf AD; Krempien R; Rommelaere J; Schlehofer JR
    Bioeng Bugs; 2010; 1(6):429-33. PubMed ID: 21468212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of glioma in rat models by intranasal application of parvovirus h-1.
    Kiprianova I; Thomas N; Ayache A; Fischer M; Leuchs B; Klein M; Rommelaere J; Schlehofer JR
    Clin Cancer Res; 2011 Aug; 17(16):5333-42. PubMed ID: 21715567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.
    Trinkaus M; Vranic A; Dolenc VV; Lah TT
    Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of cathepsins B, H and L in proximal tubules from polycystic kidneys of the Han:SPRD rat.
    Schaefer L; Han X; Gretz N; Schaefer RM
    Kidney Int; 1996 Aug; 50(2):424-31. PubMed ID: 8840269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine cathepsins are not critical for TRAIL- and CD95-induced apoptosis in several human cancer cell lines.
    Špes A; Sobotic B; Turk V; Turk B
    Biol Chem; 2012 Dec; 393(12):1417-31. PubMed ID: 23667901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells.
    Colella R; Casey SF
    Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
    Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
    Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases.
    Mason RW; Sol-Church K; Abrahamson M
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):833-8. PubMed ID: 9480898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models.
    Geletneky K; Kiprianova I; Ayache A; Koch R; Herrero Y Calle M; Deleu L; Sommer C; Thomas N; Rommelaere J; Schlehofer JR
    Neuro Oncol; 2010 Aug; 12(8):804-14. PubMed ID: 20299703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin-dependent apoptosis triggered by supraoptimal activation of T lymphocytes: a possible mechanism of high dose tolerance.
    Michallet MC; Saltel F; Flacher M; Revillard JP; Genestier L
    J Immunol; 2004 May; 172(9):5405-14. PubMed ID: 15100281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitization to the lysosomal cell death pathway upon immortalization and transformation.
    Fehrenbacher N; Gyrd-Hansen M; Poulsen B; Felbor U; Kallunki T; Boes M; Weber E; Leist M; Jäättelä M
    Cancer Res; 2004 Aug; 64(15):5301-10. PubMed ID: 15289336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and the role of cathepsin H in human glioma progression and invasion.
    Sivaparvathi M; Sawaya R; Gokaslan ZL; Chintala SK; Rao JS
    Cancer Lett; 1996 Jun; 104(1):121-6. PubMed ID: 8640738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing.
    Dahl SW; Halkier T; Lauritzen C; Dolenc I; Pedersen J; Turk V; Turk B
    Biochemistry; 2001 Feb; 40(6):1671-8. PubMed ID: 11327826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal cysteine proteinases in rat epididymis.
    Tomomasa H; Waguri S; Umeda T; Koiso K; Kominami E; Uchiyama Y
    J Histochem Cytochem; 1994 Mar; 42(3):417-25. PubMed ID: 8308258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia inhibits TRAIL-induced tumor cell apoptosis: involvement of lysosomal cathepsins.
    Nagaraj NS; Vigneswaran N; Zacharias W
    Apoptosis; 2007 Jan; 12(1):125-39. PubMed ID: 17136492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells.
    Knight MJ; Riffkin CD; Muscat AM; Ashley DM; Hawkins CJ
    Oncogene; 2001 Sep; 20(41):5789-98. PubMed ID: 11593384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress.
    Kågedal K; Johansson U; Ollinger K
    FASEB J; 2001 Jul; 15(9):1592-4. PubMed ID: 11427496
    [No Abstract]   [Full Text] [Related]  

  • 19. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L.
    Fröhlich E; Möhrle M; Klessen C
    Arch Dermatol Res; 2004 Mar; 295(10):411-21. PubMed ID: 14767779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cysteine proteinases and their inhibitor, cystatin beta, in cultured rat mesangial cells.
    Makita Y; Ishidoh K; Kominami E; Funabiki K; Koide H; Tomino Y
    J Diabetes Complications; 1998; 12(6):328-36. PubMed ID: 9877467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.